Polyclonal Antibody to Matrix Metalloproteinase 2 (MMP2)
| Code | Size | Price |
|---|
| PAA100Hu01-20ul | 20ul | £64.00 |
Quantity:
| PAA100Hu01-100ul | 100ul | £109.00 |
Quantity:
| PAA100Hu01-200ul | 200ul | £143.00 |
Quantity:
| PAA100Hu01-1ml | 1ml | £312.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunocytochemistry (ICC)
- Immunohistochemistry- Frozen Section (IHC-F)
- Immunohistochemistry- Paraffin Embedded (IHC-P)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
CLG4; CLG4A; MMP-II; MONA; TBE-1; PEX; Gelatinase A; 72kDa Gelatinase; 72kDa Type IV Collagenase
Buffer Formulation:
0.01M PBS, pH7.4, containing 0.01% Proclin-300, 50% glycerol.
Item Name:
Matrix Metalloproteinase 2
Reactivity:
Mu;Ra;
Source:
Polyclonal antibody preparation
Usage:
Western blotting: 0.5-3ug/mL<br/>Immunohistochemistry: 5-30ug/mL<br/>Immunocytochemistry: 5-30ug/mL<br/>Optimal working dilutions must be determined by end user.
References
https://wwwnature.fenshishang.com/articles/s41598-021-02454-1; https://www.researchsquare.com/article/rs-1392189/latest.pdf; https://www.researchsquare.com/article/rs-2319552/latest.pdf;
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Matrix Metalloproteinase 2 (MMP2) | RPA100Hu01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||